Aufgrund der aktuellen politischen Situation und der damit verbundenen besonderen Marktsituation sind die skontroführenden Makler im Skontroführerhandel bzw. die Market Maker der elektronischen Handelssysteme bis auf weiteres von den Handelsgarantien befreit.

Bachem Holding AG Namens-Aktien SF 0,01

ISIN: CH1176493729 WKN: A3DLKE Marktsegment: Freiverkehr

0 EUR

0% 0

Kursdaten

  • Börse Quotrix
  • Update 03.01.70 00:00 Uhr
  • Geld 0
  • Geld Stk. 0
  • Brief 0
  • Brief Stk. 0
  • Spread 0
  • Letzter 0
  • Änderung 0 %
  • Stand 01.01.70 00:00 Uhr
  • Eröffnung 0
  • Vortag 0
  • Gehandelt Stücke 0
  • Gehandelt Umsatz 0
  • Tageshoch 0
  • Tagestief 0
  • 52W Hoch 116,60 (20.06.19)
  • 52W Tief 110,20 (21.05.19)

Stammdaten

  • Wertpapiertyp Stammaktien
  • ISIN CH1176493729
  • WKN A3DLKE
  • Währung EUR
  • Erstnotierung 09.05.2022

Fundamentaldaten

  • Hauptversammlung 10.04.2019

Portrait

Bachem is an independent, technology-based company specializing in the production of innovative biochemical and pharmaceutical compounds and the development of manufacturing processes. Complementary services are geared to support customers from dedicated syntheses of defined target structures up to the registration of new compounds. With headquarters in Bubendorf, Switzerland, and group companies in Europe and the US, Bachem works on a global scale and holds a leading position in its field. Facilities in Switzerland and in the US, approved by international regulatory authorities and suitable also for the large scale production of active ingredients, make Bachem a partner for all major pharmaceutical companies. Based on its dedication to research, Bachem also offers opportunities to innovative technology partners for collaborations on future active substances. The company employs 575 motivated and qualified people worldwide. In its activities, Bachem is committed to its customers, employees and shareholders, as well as to the environment and society as a whole. Bachem´s contribution to the development and production of pharmaceutical compounds benefits these constituencies and contributes to secure the long-term future of the company.

Newsbox Finanznachrichten.de

Kennzahlen
(Times & Sales)
Historische Kurse